TANGO AND ERASCA INITIATE PHASE 1/2 STUDY OF ORAL PRMT5 INHIBITOR VOPIMETOSTAT IN COMBINATION WITH PAN-RAS MOLECULAR GLUE ERAS-0015

Reuters · 18h ago

Please log in to view news